Researchers at Columbia University and the New York Genome Center have developed a cost-effective method to quickly and accurately identify people and cell lines from DNA. This new software could be useful for recognizing mislabeled or contaminated cell lines for cancer experiments. The findings were published this week in eLife.

Subscribe to eNewsletters
Get the latest industry news and technology updates
related to your research interests.

The technology runs on the MinION, a small, $1,000 instrument that pulls strands of DNA through microscopic pores and reads out nucleotide sequences. The MinION had previously been used mostly for sequencing bacteria and viruses, as its high error rate and large sequencing gaps limited its use for analyzing human cells.

To overcome these challenges, the researchers created software that utilizes the abundance of human genetic data now available online. First the MinION is used to sequence random strings of DNA, from which individual variants are selected. A Bayesian algorithm is then used to randomly compare this mix of variants with corresponding variants in other genetic profiles in the file. In each cross-check that occurs, the algorithm updates the likelihood of finding a match, thus narrowing the search. 

According to the researchers, the software was able to identify the lead author’s identity from a cheek swab within minutes.

To confirm the software’s use in cell authentication, the scientists matched a strain of leukemic cells against a reference file in the Cancer Cell Line Encyclopedia database. When they contaminated the cells with other cultures, it was able to correctly reject a match if those contamination levels climbed above 25%.

With the recent focus on increasing reproducibility, the authors believe this technology could be a good resource for scientists looking for a cheap, rapid and effective way to validate their cell lines.

Image: Researcher Sophie Zaaijer uses the MinION, a portable DNA sequencer, to get a quick genetic readout of a sample of cells. Image courtesy of the New York Genome Center.